Cuba administers over 62,000 doses in intervention trials Cuba administers over 62,000 doses in intervention trials Havana, Apr 5 (Prensa Latina) Over 62,000 people belonging to the controlled intervention trials with Cuba's vaccine candidates against Covid-19, Soberana 02 and Abdala, have received on Monday their first doses. The group of Cuba's Biotechnological and Pharmaceutical Industries informed so on social networks, and detailed that 61,512 volunteers from the capital received the initial injection of both vaccine candidates indistinctly. Meanwhile, another 971 subjects of the intervention study in the eastern provinces of Granma, Santiago de Cuba and Guantanamo have already received the first dose of Abdala. Soberana 02, designed by Cuba's Finlay Vaccine Institute, began its clinical trial for population segments at high risk of infection on March 23 in Havana, at the same time that it is undergoing the 3rd Phase of its clinical analysis.